FinancialContent is the trusted provider of stock market information to the media industry.
Bitcoin or CRISPR: Which is the Bigger Disruptor?
November 29, 2017
Don't Fight the Gravity of Exponential Change
November 22, 2017
Disruptor Alert: These 5 Companies Are Changing Healthcare
November 14, 2017
Barclays: Editas Medicine On Track To File New Drug App Next Year
November 08, 2017
Why CRISPR Therapeutics AG Stock Edged Higher in October
November 07, 2017
The 1 Stock You've Been Overlooking for Your Roth IRA
October 15, 2017
Why CRISPR Therapeutics AG Stock Lost Ground in September
October 10, 2017
3 Reasons To Like Vertex Pharma Shares
September 29, 2017
Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?
September 28, 2017
2 Views on Vertex Pharmaceuticals Stock: Short Term vs. Long Term
September 12, 2017
Breaking Down Barclays' New Bullish Calls On Biotech
September 07, 2017
Why You're Smart to Buy Vertex Pharmaceuticals Stock
July 15, 2017
Why CRISPR Therapeutics AG Jumped 11.7% in June
July 10, 2017
3 Growth Stocks for Forward-Looking Investors
July 09, 2017
22 Stocks Moving In Wednesday's Pre-Market Session
June 28, 2017
22 Stocks Moving In Monday's Pre-Market Session
June 12, 2017
3 Stocks I'd Never Touch
March 06, 2017
Here's Why Editas Medicine Jumped 32.6% Higher Today
February 15, 2017
Why Crisper Therapeutics Tumbled 12.4% in January
February 07, 2017
5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond
January 09, 2017
Is This Why CRISPR Therapeutics Stock Rallied 21.6% in November?
December 06, 2016
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial